Citicoline (CDP-Choline)
An RCT in healthy older adults (Spiers et al., 1996) found 1000mg/day improved delayed verbal recall in people with relatively inefficient memory, with 2000mg/day improving immediate and delayed recall. A 2023 meta-analysis found a positive effect on cognitive status in MCI and dementia, but rated study quality poor with a high risk of bias. The 2005 Cochrane review found benefit on memory and behaviour in older adults with chronic cerebral disorders but no evidence of benefit on attention. In acute ischemic stroke, a dose-response RCT (Clark 1997) found better functional outcomes, with 500mg the optimal dose.
Evidence reviewed:
Mechanism of action
Citicoline (cytidine 5'-diphosphocholine) is a precursor to both acetylcholine and phosphatidylcholine. It boosts acetylcholine synthesis in the brain — the neurotransmitter central to attention, learning, and memory encoding. It also supports neuronal membrane integrity by replenishing phospholipids.
Clinical evidence summary
An RCT in healthy older adults (Spiers et al., 1996) found 1000mg/day improved delayed verbal recall in people with relatively inefficient memory, with 2000mg/day improving immediate and delayed recall. A 2023 meta-analysis found a positive effect on cognitive status in MCI and dementia, but rated study quality poor with a high risk of bias. The 2005 Cochrane review found benefit on memory and behaviour in older adults with chronic cerebral disorders but no evidence of benefit on attention. In acute ischemic stroke, a dose-response RCT (Clark 1997) found better functional outcomes, with 500mg the optimal dose.
Human effect matrix
Based on human clinical trials only. Animal and in-vitro data excluded.
| Effect | Evidence | Magnitude | Studies |
|---|---|---|---|
| Attention & Focus | mixed | Small | 2 |
| Working Memory | moderate | Moderate | 2 |
| Neuroprotection | moderate | Moderate | 1 |
Evidence key: Strong = multiple consistent RCTs · Moderate = smaller/fewer RCTs · Preliminary = early trials or small n · Mixed = conflicting results
Documented benefits
- Verbal memory in older adults with weaker memory
- Cognitive status in MCI and dementia (low-quality evidence)
- Functional recovery after ischemic stroke (one RCT)
Side effects & cautions
- Very well tolerated — no drug-related serious adverse events in the stroke dose-response RCT
- Rare: headache at very high doses
- Insomnia if taken late in the day
How to take
Stacking recommendations
Ingredients that pair well with Citicoline (CDP-Choline) and why.
Citicoline handles acute attention and acetylcholine; Bacopa covers long-term memory consolidation. The combination addresses both short-term focus and long-term memory in one stack.
Citicoline provides cognitive activation; L-Theanine takes the edge off overstimulation. Together they produce alert, focused calm without the jitteriness some people experience from citicoline alone.
Complementary timeframes: citicoline works acutely on acetylcholine; Lion's Mane works long-term on NGF. No mechanism overlap — a clean combination.
Frequently asked questions
Citicoline vs choline bitartrate — what is the difference?
Citicoline is significantly superior. It crosses the blood-brain barrier more efficiently and provides two active components: choline (for acetylcholine) and cytidine (which converts to uridine, a brain membrane building block). Choline bitartrate provides choline only and crosses the BBB poorly.
Should I split my dose?
At 250mg, a single morning dose is fine. At 500mg, some people split it into 250mg morning and 250mg early afternoon for smoother coverage. Avoid any dose after 2–3pm as the mildly activating effect can delay sleep onset.
I got a headache after taking citicoline — is this normal?
A headache from citicoline at standard doses (250–500mg) is unusual and may indicate you are sensitive to cholinergic compounds or already getting significant choline from diet/other supplements. Try reducing to 250mg and do not combine with Alpha-GPC or other choline sources on the same day.
Cognizin vs generic CDP-Choline — does the brand matter?
Cognizin is the most clinically validated form and is tested for purity. Generic CDP-Choline can be fine if sourced from reputable suppliers, but quality varies more. For critical cognitive work, the premium branded form is worth the marginal cost increase.
Top stacks containing Citicoline (CDP-Choline)
Citicoline (CDP-Choline) in Canada
Citicoline is recognized in Health Canada's Natural Health Products Ingredients Database (NHPID) and covered by the "Cognitive function products" natural health product monograph, which sets the daily dose and label wording a Canadian-licensed citicoline product attesting to it can use. The NHPID lists citicoline as "Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations." The monograph lists two uses for citicoline with two dose ranges, both capped at 500 mg per single dose — a narrower frame than the general clinical dosing this site already covers.
Health Canada's monograph uses and doses
In the "Cognitive function products" monograph, citicoline appears under the use "Helps (to) improve sustained attention" at "250-1000 milligrams per day; not to exceed 500 milligrams per single dose," and under the use "Helps (to) support cognitive health and/or brain function in older adults" at 500-1000 milligrams per day with the same 500 mg single-dose cap. These are the use-and-dose pairs the monograph provides for citicoline.
What the NHPID entry adds
The NHPID entry is the reference a licence application uses for the ingredient's proper name, classification and source material: citicoline is listed as "Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations." The approved use and dose come separately from the monograph. Together they are the two Health Canada reference points a Canadian buyer can compare against a label, in place of a manufacturer-written claim.
Products in Canada
Health Canada (NPN)
What citicoline dose does Health Canada's monograph allow?
Two uses are listed. "Helps (to) improve sustained attention" is permitted at "250-1000 milligrams per day; not to exceed 500 milligrams per single dose." "Helps (to) support cognitive health and/or brain function in older adults" is permitted at 500-1000 milligrams per day, also capped at 500 mg per single dose.
Is citicoline classified as an isolate or a whole-herb ingredient in Canada?
Health Canada's NHPID lists citicoline as "Classified as an NHP under Schedule 1, item 2 (an isolate) of the Natural Health Products Regulations," the same classification given to L-theanine. The NHPID entry is the reference for the ingredient's name, classification and source material; the approved use and dose come from the monograph.
Sources: NHPID — Chemical Substance: Citicoline · Health Canada — Natural Health Product Monograph: Cognitive Function Products (PDF) · Health Canada — Cognitive function products monograph, citicoline use (sustained attention) · Health Canada — Cognitive function products monograph, citicoline use (older adults)
Regulatory note
Natural health products available in Canada are regulated by Health Canada under the Natural Health Products Regulations. Where a product holds an NPN (Natural Product Number), Health Canada says that number "assures consumers that the product has been reviewed and approved by Health Canada for safety and efficacy"; it also states, "To be licensed in Canada, natural health products must be safe, effective, of high quality" (canada.ca, checked 2026-10-08). Cross-border imports without an NPN are not Health Canada licensed. This page is for educational purposes only and is not medical advice. Consult a qualified healthcare professional before starting any supplement.
Sources (6)expand
- PMID 15846601Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly (2005)
- PMID 36678257Is Citicoline Effective in Preventing and Slowing Down Dementia? – A Systematic Review and a Meta-Analysis (2023)
- PMID 8624220Citicoline improves verbal memory in aging (1996)
- PMID 9305321A randomized dose-response trial of citicoline in acute ischemic stroke patients (1997)
- PMID 25046515Improvements in concentration, working memory and sustained attention following consumption of a natural citicoline-caffeine beverage (2014)
- PMID 41754112The Real-World Early Neuroprotective Effects of Oral Citicoline Combination in Prodromal Dementia (2026)